. 2021 Jul 7;36(1):1574–1602. doi: 10.1080/14756366.2021.1937143
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 8.
Chemical structures of pyrrolopyrimidine-based Lck inhibitors 5–23.